Screening of bifidobacteria and lactobacilli able to antagonise the cytotoxic effect of Clostridium difficile upon intestinal epithelial HT29 monolayer

Clostridium difficile is an opportunistic pathogen inhabiting the human gut, often being the aetiological agent of infections after a microbiota dysbiosis following, for example, an antibiotic treatment. C. difficile infections (CDI) constitute a growing health problem with increasing rates of morbi...

Full description

Bibliographic Details
Main Authors: Lorena eValdés-Varela, Marta eAlonso-Guervos, Olivia eGarcía-Suárez, Miguel eGueimonde, Patricia eRuas-Madiedo
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-04-01
Series:Frontiers in Microbiology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fmicb.2016.00577/full
_version_ 1819064037964513280
author Lorena eValdés-Varela
Marta eAlonso-Guervos
Olivia eGarcía-Suárez
Miguel eGueimonde
Patricia eRuas-Madiedo
author_facet Lorena eValdés-Varela
Marta eAlonso-Guervos
Olivia eGarcía-Suárez
Miguel eGueimonde
Patricia eRuas-Madiedo
author_sort Lorena eValdés-Varela
collection DOAJ
description Clostridium difficile is an opportunistic pathogen inhabiting the human gut, often being the aetiological agent of infections after a microbiota dysbiosis following, for example, an antibiotic treatment. C. difficile infections (CDI) constitute a growing health problem with increasing rates of morbidity and mortality at groups of risk, such as elderly and hospitalized patients, but also in populations traditionally considered low-risk. This could be related to the occurrence of virulent strains which, among other factors, have high-level of resistance to fluoroquinolones, more efficient sporulation and markedly high toxin production. Several novel intervention strategies against CDI are currently under study, such as the use of probiotics to counteract the growth and/or toxigenic activity of C. difficile.In this work, we have analysed the capability of twenty Bifidobacterium and Lactobacillus strains, from human intestinal origin, to counteract the toxic effect of C. difficile LMG21717 upon the human intestinal epithelial cell line HT29. For this purpose, we incubated the bacteria together with toxigenic supernatants obtained from C. difficile. After this co-incubation new supernatants were collected in order to quantify the remnant A and B toxins, as well as to determine their residual toxic effect upon HT29 monolayers. To this end, the real time cell analyser (RTCA) model, recently developed in our group to monitor C. difficile toxic effect, was used. Results obtained showed that strains of Bifidobacterium longum and Bifidobacterium breve were able to reduce the toxic effect of the pathogen upon HT29, the RTCA normalized cell-index values being inversely correlated with the amount of remnant toxin in the supernatant. The strain B. longum IPLA20022 showed the highest ability to counteract the cytotoxic effect of C. difficile acting directly against the toxin, also having the highest capability for removing the toxins from the clostridial toxigenic supernatant. Image analysis showed that this strain prevents HT29 cell rounding; this was achieved by preserving the F-actin microstructure and tight-junctions between adjacent cells, thus keeping the typical epithelium-like morphology. Besides, preliminary evidence showed that the viability of B. longum IPLA20022 is needed to exert the protective effect and that secreted factors seems to have anti-toxin activity.
first_indexed 2024-12-21T15:24:12Z
format Article
id doaj.art-758e181eb63b4678b867d21820eefa9f
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-12-21T15:24:12Z
publishDate 2016-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-758e181eb63b4678b867d21820eefa9f2022-12-21T18:58:57ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2016-04-01710.3389/fmicb.2016.00577183419Screening of bifidobacteria and lactobacilli able to antagonise the cytotoxic effect of Clostridium difficile upon intestinal epithelial HT29 monolayerLorena eValdés-Varela0Marta eAlonso-Guervos1Olivia eGarcía-Suárez2Miguel eGueimonde3Patricia eRuas-Madiedo4Instituto de Productos Lácteos de Asturias - Consejo Superior de Investigaciones Científicas (IPLA-CSIC)University of OviedoUniversity of OviedoInstituto de Productos Lácteos de Asturias - Consejo Superior de Investigaciones Científicas (IPLA-CSIC)Instituto de Productos Lácteos de Asturias - Consejo Superior de Investigaciones Científicas (IPLA-CSIC)Clostridium difficile is an opportunistic pathogen inhabiting the human gut, often being the aetiological agent of infections after a microbiota dysbiosis following, for example, an antibiotic treatment. C. difficile infections (CDI) constitute a growing health problem with increasing rates of morbidity and mortality at groups of risk, such as elderly and hospitalized patients, but also in populations traditionally considered low-risk. This could be related to the occurrence of virulent strains which, among other factors, have high-level of resistance to fluoroquinolones, more efficient sporulation and markedly high toxin production. Several novel intervention strategies against CDI are currently under study, such as the use of probiotics to counteract the growth and/or toxigenic activity of C. difficile.In this work, we have analysed the capability of twenty Bifidobacterium and Lactobacillus strains, from human intestinal origin, to counteract the toxic effect of C. difficile LMG21717 upon the human intestinal epithelial cell line HT29. For this purpose, we incubated the bacteria together with toxigenic supernatants obtained from C. difficile. After this co-incubation new supernatants were collected in order to quantify the remnant A and B toxins, as well as to determine their residual toxic effect upon HT29 monolayers. To this end, the real time cell analyser (RTCA) model, recently developed in our group to monitor C. difficile toxic effect, was used. Results obtained showed that strains of Bifidobacterium longum and Bifidobacterium breve were able to reduce the toxic effect of the pathogen upon HT29, the RTCA normalized cell-index values being inversely correlated with the amount of remnant toxin in the supernatant. The strain B. longum IPLA20022 showed the highest ability to counteract the cytotoxic effect of C. difficile acting directly against the toxin, also having the highest capability for removing the toxins from the clostridial toxigenic supernatant. Image analysis showed that this strain prevents HT29 cell rounding; this was achieved by preserving the F-actin microstructure and tight-junctions between adjacent cells, thus keeping the typical epithelium-like morphology. Besides, preliminary evidence showed that the viability of B. longum IPLA20022 is needed to exert the protective effect and that secreted factors seems to have anti-toxin activity.http://journal.frontiersin.org/Journal/10.3389/fmicb.2016.00577/fullBifidobacteriumClostridium difficileLactobacillusMicroscopyProbioticstoxins
spellingShingle Lorena eValdés-Varela
Marta eAlonso-Guervos
Olivia eGarcía-Suárez
Miguel eGueimonde
Patricia eRuas-Madiedo
Screening of bifidobacteria and lactobacilli able to antagonise the cytotoxic effect of Clostridium difficile upon intestinal epithelial HT29 monolayer
Frontiers in Microbiology
Bifidobacterium
Clostridium difficile
Lactobacillus
Microscopy
Probiotics
toxins
title Screening of bifidobacteria and lactobacilli able to antagonise the cytotoxic effect of Clostridium difficile upon intestinal epithelial HT29 monolayer
title_full Screening of bifidobacteria and lactobacilli able to antagonise the cytotoxic effect of Clostridium difficile upon intestinal epithelial HT29 monolayer
title_fullStr Screening of bifidobacteria and lactobacilli able to antagonise the cytotoxic effect of Clostridium difficile upon intestinal epithelial HT29 monolayer
title_full_unstemmed Screening of bifidobacteria and lactobacilli able to antagonise the cytotoxic effect of Clostridium difficile upon intestinal epithelial HT29 monolayer
title_short Screening of bifidobacteria and lactobacilli able to antagonise the cytotoxic effect of Clostridium difficile upon intestinal epithelial HT29 monolayer
title_sort screening of bifidobacteria and lactobacilli able to antagonise the cytotoxic effect of clostridium difficile upon intestinal epithelial ht29 monolayer
topic Bifidobacterium
Clostridium difficile
Lactobacillus
Microscopy
Probiotics
toxins
url http://journal.frontiersin.org/Journal/10.3389/fmicb.2016.00577/full
work_keys_str_mv AT lorenaevaldesvarela screeningofbifidobacteriaandlactobacilliabletoantagonisethecytotoxiceffectofclostridiumdifficileuponintestinalepithelialht29monolayer
AT martaealonsoguervos screeningofbifidobacteriaandlactobacilliabletoantagonisethecytotoxiceffectofclostridiumdifficileuponintestinalepithelialht29monolayer
AT oliviaegarciasuarez screeningofbifidobacteriaandlactobacilliabletoantagonisethecytotoxiceffectofclostridiumdifficileuponintestinalepithelialht29monolayer
AT miguelegueimonde screeningofbifidobacteriaandlactobacilliabletoantagonisethecytotoxiceffectofclostridiumdifficileuponintestinalepithelialht29monolayer
AT patriciaeruasmadiedo screeningofbifidobacteriaandlactobacilliabletoantagonisethecytotoxiceffectofclostridiumdifficileuponintestinalepithelialht29monolayer